Dashboard
Manage Tickers

MNKDMANNKIND CORP

Nasdaq mannkindcorp.com


$ 5.01 $ 0.00 (0 %)    

Wednesday, 03-Jul-2024 12:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ na
$ 5.07
$ 0.00 x 0
$ 0.00 x 0
$ 4.99 - $ 5.24
$ 3.17 - $ 5.75
873,859
na
1.63B
$ 1.14
$ 192.46
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-mannkinds-inhaled-insulin-afrezza-shows-results-in-17-week-study
Reported Earlier, MannKind's Inhaled Insul...
06/24/2024 07:04:21

 MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products...

rodman--renshaw-initiates-coverage-on-mannkind-with-buy-rating-announces-price-target-of-8
Rodman & Renshaw Initiates Coverage On Man...
06/13/2024 17:42:02

Rodman & Renshaw analyst Brandon Folkes initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Pri...

Core News & Articles
Pulmatrix Enters Cross License Agreement W...
05/29/2024 12:49:00

cantor-fitzgerald-reiterates-overweight-on-mannkind-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/09/2024 14:56:24

Cantor Fitzgerald analyst Olivia Brayer reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $6.5 price target.

mannkind-q1-2024-adj-eps-005-beats-003-estimate-sales-66263m-beat-60490m-estimate
MannKind Q1 2024 Adj EPS $0.05 Beats $0.03...
05/08/2024 20:42:59

MannKind (NASDAQ:MNKD) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66....

mannkind-announced-the-fda-fast-track-designation-for-clofazimine-inhalation-suspension-mnkd-101-for-nontuberculous-mycobacterial-lung-disease
MannKind Announced The FDA Fast Track Desi...
05/06/2024 10:10:08

mannkind-will-proceed-with-phase-1-nintedanib-dpi-mnkd-201-study-for-pulmonary-fibrotic-diseases
MannKind Will Proceed With Phase 1 Ninteda...
04/30/2024 10:07:46

mannkind-announces-ind-clearance-from-us-fda-to-start-phase-3-study-of-clofazimine-inhalation-suspension-for-nontuberculous-mycobacterial-ntm-lung-disease
MannKind Announces IND Clearance From US F...
04/29/2024 10:07:05

MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of innovative inhaled therapeuti...

mannkind-announced-that-it-has-repaid-in-full-all-outstanding-indebtedness-under-both-its-credit-and-security-agreement-with-midcap-financial-trust-and-its-convertible-promissory-note-issued-to-mann-group-llc
MannKind Announced That It Has Repaid In F...
04/03/2024 10:06:44

Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 million Convertible note is...

mannkind-appoints-christopher-prentiss-as-cfo-effective-april-22-2024-succeeds-steven-binder
MannKind Appoints Christopher Prentiss As ...
03/26/2024 20:07:38

cantor-fitzgerald-reiterates-overweight-on-mannkind-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
03/15/2024 14:51:51

Cantor Fitzgerald analyst Olivia Brayer reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $6.5 price target.

why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Mesoblast Shares Are Trading Higher By...
03/11/2024 17:41:28

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

eqt-genie-energy-and-other-big-stocks-moving-lower-on-monday
EQT, Genie Energy And Other Big Stocks Mov...
03/11/2024 14:37:32

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

whats-going-on-with-mannkind-stock
What's Going On With MannKind Stock?
03/11/2024 14:28:31

MannKind Corporation shares are trending on social media Monday. CNBC's Jim Cramer mentioned the stock on the "Mad Mone...

mannkind-announced-initial-meal-challenge-data-from-inhale-3-phase-4-us-trial-comparing-afrezza-head-to-head-with-multiple-daily-injections-and-insulin-pumps
MannKind Announced Initial Meal Challenge ...
03/11/2024 10:13:58

Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered th...

cramer-says-sprout-social-is-in-a-hot-spot-but-this-energy-stock-is-too-down-and-out
Cramer Says Sprout Social Is In A 'Hot Spo...
03/08/2024 14:13:15

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he needs to do more work on Sprout Social, Inc. (NASDAQ: SPT) ...

mannkind-announced-that-new-clinical-data-from-inhale-3-phase-4-study-of-inhaled-insulin-plus-basal-vs-standard-of-care-at-the-international-conference-on-advanced-technologies-and-treatments-for-diabetes
MannKind Announced That New Clinical Data ...
03/05/2024 11:08:06

cantor-fitzgerald-reiterates-overweight-on-mannkind-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
02/28/2024 16:22:52

Cantor Fitzgerald analyst Olivia Brayer reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $6.5 price target.

mannkind-q4-2023-adj-eps-002-beats-undefined-estimate-sales-5847m-beat-5358m-estimate
MannKind Q4 2023 Adj EPS $0.02 Beats undef...
02/27/2024 21:05:16

MannKind (NASDAQ:MNKD) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of undefined by...

earnings-scheduled-for-february-27-2024
Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)